Entity Common Stock, Shares Outstanding of Tvardi Therapeutics, Inc. from Q1 2014 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tvardi Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q1 2014 to Q3 2025.
  • Tvardi Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 10 Nov 2025 was 9,381,344 shares, a 82.9% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Tvardi Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 9,381,344 -45,474,170 -82.9% 10 Nov 2025 10-Q 13 Nov 2025
Q2 2025 9,377,433 -45,469,206 -82.9% 08 Aug 2025 10-Q 14 Aug 2025
Q1 2025 4,573,606 -50,082,807 -91.6% 06 Mar 2025 10-K 11 Mar 2025
Q3 2024 54,855,514 +374,810 +0.69% 11 Nov 2024 10-Q 14 Nov 2024
Q2 2024 54,846,639 +768,958 +1.4% 09 Aug 2024 10-Q 14 Aug 2024
Q1 2024 54,656,413 +713,060 +1.3% 01 Mar 2024 10-K 06 Mar 2024
Q3 2023 54,480,704 +747,097 +1.4% 09 Nov 2023 10-Q 13 Nov 2023
Q2 2023 54,077,681 +351,756 +0.66% 03 Aug 2023 10-Q 07 Aug 2023
Q1 2023 53,943,353 +352,128 +0.66% 02 Mar 2023 10-K 06 Mar 2023
Q3 2022 53,733,607 +274,928 +0.51% 03 Nov 2022 10-Q 07 Nov 2022
Q2 2022 53,725,925 +3,635,989 +7.3% 04 Aug 2022 10-Q 08 Aug 2022
Q1 2022 53,591,225 +3,539,214 +7.1% 05 May 2022 10-Q 09 May 2022
Q3 2021 53,458,679 +3,626,575 +7.3% 04 Nov 2021 10-Q 08 Nov 2021
Q2 2021 50,089,936 +3,203,185 +6.8% 05 Aug 2021 10-Q 09 Aug 2021
Q1 2021 50,052,011 +3,326,786 +7.1% 06 May 2021 10-Q 10 May 2021
Q3 2020 49,832,104 +3,153,127 +6.8% 05 Nov 2020 10-Q 09 Nov 2020
Q2 2020 46,886,751 +469,051 +1% 06 Aug 2020 10-Q 10 Aug 2020
Q1 2020 46,725,225 +7,177,667 +18.1% 24 Feb 2020 10-K 27 Feb 2020
Q3 2019 46,678,977 +7,232,220 +18.3% 01 Nov 2019 10-Q 05 Nov 2019
Q2 2019 46,417,700 +7,127,236 +18.1% 02 Aug 2019 10-Q 07 Aug 2019
Q1 2019 39,547,558 +6,857,322 +21% 05 Mar 2019 10-K 12 Mar 2019
Q3 2018 39,446,757 +6,838,272 +21% 01 Nov 2018 10-Q 06 Nov 2018
Q2 2018 39,290,464 +6,708,979 +20.6% 01 Aug 2018 10-Q 07 Aug 2018
Q1 2018 32,690,236 +182,749 +0.56% 08 Mar 2018 10-K 15 Mar 2018
Q3 2017 32,608,485 +5,325,622 +19.5% 27 Oct 2017 10-Q 02 Nov 2017
Q2 2017 32,581,485 +5,298,622 +19.4% 28 Jul 2017 10-Q 03 Aug 2017
Q1 2017 32,507,487 +5,252,624 +19.3% 28 Apr 2017 10-Q 04 May 2017
Q3 2016 27,282,863 +51,280 +0.19% 28 Oct 2016 10-Q 04 Nov 2016
Q2 2016 27,282,863 +117,988 +0.43% 29 Jul 2016 10-Q 04 Aug 2016
Q1 2016 27,254,863 +4,429,944 +19.4% 03 Mar 2016 10-K 11 Mar 2016
Q3 2015 27,231,583 +4,452,986 +19.5% 04 Nov 2015 10-Q 09 Nov 2015
Q2 2015 27,164,875 +4,520,078 +20% 05 Aug 2015 10-Q 10 Aug 2015
Q1 2015 22,824,919 +222,922 +0.99% 20 Mar 2015 10-K 27 Mar 2015
Q3 2014 22,778,597 05 Nov 2014 10-Q 10 Nov 2014
Q2 2014 22,644,797 05 Aug 2014 10-Q 07 Aug 2014
Q1 2014 22,601,997 05 May 2014 10-Q 12 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.